Navigation Links
Titanium Group Announces Biometric Contract with One of the Most Active Clinics in Hong Kong
Date:11/27/2007

New Applications of Titanium's Core Technology in the Health Care Industry

SAN JOSE, Calif., Nov. 27 /PRNewswire-FirstCall/ -- Titanium Group, Ltd (OTC Bulletin Board: TTNUF), a leading biometric and security solutions provider announced today it has signed a contract with Hong Kong Polytechnic University Clinic for the installation of a biometric pharmacy system powered by Titanium's Biometric Facial Recognition technology. In this newly designed application, all patients, together with their corresponding medical histories, are registered into the system. After each visit, the patients would then be required to verify their identities before collecting their medication, ensuring that everyone will be taking the correct drugs prescribed by the physicians.

"Given there have been cases in other clinics where patients took the wrong drug leading to very serious problems, this system is designed specifically for the clinic to avoid any potential occurrence of such a nature, and thus liability, for the clinic. This use of Titanium's Biometric Facial Recognition technologies is a ground-breaking application of our products and we are excited to see our technologies working effectively, now in the healthcare industry. This is a very large and growing sector which is full of market potential for our products in the region," said Billy Tang, COO of Titanium Group Ltd.

The Clinic provides primary health care services, nursing practices, dispensary and laboratory services, health education and promotion, and TCM service. Over 20,000 full time students, staff and their dependents, as well as retirees on the campus of approximately 93,500 square meters are covered by this service.

About Titanium Group:

Titanium Group, Ltd (http://www.titanium-tech.com), and its wholly owned subsidiary Titanium Technology, is a leading biometric and security solutions provider featuring its proprietar
'/>"/>

SOURCE Titanium Group, Ltd
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology news :

1. Titanium Group Announces Contract With Haitong Securities
2. Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network
3. Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar
4. Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network
5. UF botanists: Flowering plants evolved very quickly into 5 groups
6. Tree of life for flowering plants reveals relationships among major groups
7. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
8. LaserCard Corporation Announces Expansion of Middle East Project
9. BIO-key(R) Announces Contracts for New Criminal Justice Data Sharing Solution
10. Balzan Foundation announces 2007 winners
11. The American Society of Plant Biologists announces 2007 awards

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...n,s most distinctive residents. ,Everyone wants to..., says Michelle McComb from Florida Atlantic Unive...,Perhaps their visual field has been enhanced by t...arks excellent stereovision and depth perception. ...ls of thought on this theory. In 1942, G. Walls sp...
(Date:11/26/2009)...ed deer have been caught in the hunters, sights fo...than decorative. They are lethal weapons that stag...The University of York, UK, has been intrigued by ...century and has become fascinated by the mechanica...laboration with Tomas Landete-Castillejos at the U...
(Date:11/26/2009)...ay of using recordings of birdsong to accurately m...irst time sound recordings from a microphone array...ird species, populations. Because the new techniqu...ournal of Applied Ecology , will also work with wh...ability to monitor whale and dolphin numbers. , ...
Breaking Biology News(10 mins):Wide heads give hammerheads exceptional stereo view 2Tough yet stiff deer antler is materials scientist's dream 2Ecologists sound out new solution for monitoring cryptic species 2Florida 26apos 3Bs Halifax Health Relies on Standby Power System from MTU Onsite Energy for New 10 Story Emergency Facility 59788 1Florida 26apos 3Bs Halifax Health Relies on Standby Power System from MTU Onsite Energy for New 10 Story Emergency Facility 59788 2Florida 26apos 3Bs Halifax Health Relies on Standby Power System from MTU Onsite Energy for New 10 Story Emergency Facility 59788 3Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 1Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 2Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 3Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 4Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 5Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 6Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 7Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 8Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 9Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 10Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 11Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 12Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 13Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 14Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 15LIVESTRONG 28R 29 Receives 24211 306 Donation from Eagle Golf 59782 1LIVESTRONG 28R 29 Receives 24211 306 Donation from Eagle Golf 59782 2
... of the worlds leading STM publishers, has signed ...ntific societies during the past half year. With ...resentative selection of Korean society journals a...blishing the increasing amount of research coming ... journals in 2008 were signed with the Korean Soci...
...rents need to be educated about managing fever in ...ectly and often unnecessarily, according to a Quee.... , QUT senior research fellow Anne Walsh conduct...nage childhood fever as part of her PhD. , Her re...iatrics and Child Health. , Ms Walsh found that, ...
...TE, Ind. - Researchers have developed a breed of A...light that decimated its population in the early 1...o-called for its picturesque form and towering hei...lew of obstacles, said a Purdue University researc...t blight, but there is a whole new set of obstacle...
Other Biology News:Fever causing headaches for Aussie parents 2Challenges remain in reintroducing American chestnut 2Challenges remain in reintroducing American chestnut 3
(Date:11/27/2009)...wswire/--CromozInc.,locatedinResearchTrianglePark,...rdrugdeliverysysteminHyderabad,India.Thewater-solu...allsthatallowsforconjugationwithcancerdrugs,wasdev...ITT).Theconjugatedcarbonnanotubesservesasadrugdeli...hhasthepotentialtoincreasethedrugefficacy. ,, T...
(Date:11/27/2009)...wire-FirstCall/--Stallergeneshasbeen,grantedEurope...n,throughaMutualRecognitionProcedure.Germany,thefi...ferenceMemberstate. , Oralair(R)isnowregister...lic,Estonia,France,Germany,Greece,Hungary,Ireland,...lands,Poland,Portugal,Romania,Slovakia,Slovenia,a...
(Date:11/27/2009)...hanised blue dye test alternative is helping bri...nce one step closer for pharma-companies. It is a ...e developed by Sepha for use with blister packs ... and global pharma-companies such as Sanofi-Avenis...d productivity improvements on the packaging line....
(Date:11/26/2009)...new generation of ultrasmall transistors and more ...ed semiconducting nanowires are closer to reality ...e University and the University of California at L...o create nanowires with layers of different materi...which is a critical requirement for making efficie...
Breaking Biology Technology:North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3
... 29, 2009 Senomyx, Inc. (Nasdaq: SNMX ) will re... and fiscal year ending December 31, 2008 on Thurs....S. financial markets. The Company will also host...11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) t...nt will provide a business update and will discuss...
... Sigma-Aldrich (Nasdaq: SIAL ),today announced ...PC,Scientific, a leading provider of high quality ... APIs for the pharmaceutical and biotechnology ind...tific will offer Sigma-Aldrich,s,PEPscreen(R) cust...een ) to life,science researchers and pharmaceutic...
...9 Amicus Therapeutics (Nasdaq: FOLD ) will anno...esults after the regular close of markets on Thurs...ll be followed by a live conference call and webca...participants and investors may access the conferen..../Canada) or 719-325-4870 (international). A telep...
Other Biology Technology:SENOMYX, INC. fourth quarter AND FISCAL YEAR-END 2008 Earnings conference call scheduled for February 12, 2009 2Sigma-Aldrich Signs Agreement With CPC Scientific for the Distribution of PEPscreen(R) Custom Peptide Libraries 2Sigma-Aldrich Signs Agreement With CPC Scientific for the Distribution of PEPscreen(R) Custom Peptide Libraries 3Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date 2
... expression profiling and built on the flexible an...platform. These microarrays are available as part ... Service. Probe Content The Fishes microRNA Mic...que mature sequences). The comprehensive probe con...
... expression profiling and built on the flexible an...platform. These microarrays are available as part ... Service. Probe Content The Maize microRNA Micr...ue mature sequences). The comprehensive probe cont...
...itative and qualitative capabilities of the 4000 Q...w Tempo nano MDLC System plus automation software,...validation of protein biomarkers. , , Eliminate e...electivity and sensitivity. , Build methods quick...
...nce of the LTQ, incorporating more techniques to g...ntifics innovations in ion trap technology. Therm...r that offers multiple dissociation techniques, PQ...iation (PQD) is a patented technique that eliminat...
Biology Products: